Literature DB >> 11843829

A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging.

S A Klein1, H Martin, D Schreiber-Dietrich, S Hermann, W F Caspary, D Hoelzer, C F Dietrich.   

Abstract

An objective and non-invasive method to assess the extent, severity, course and prognosis of acute graft-versus-host disease (aGvHD) of the gastrointestinal tract would be of great importance. As high-resolution ultrasonography (HRU) and colour Doppler imaging (CDI) are used in inflammatory and ischaemic bowel diseases, we introduced these techniques to evaluate acute intestinal GvHD. In this study, 12 patients with suspected intestinal and/or severe cutaneous aGvHD were investigated by HRU and CDI. The structure and thickness of the bowel wall and the blood flow pattern in the superior mesenteric artery (SMA) as well as in the bowel wall were evaluated. All patients showed thickened bowel wall segments, especially in the ileocaecal region. Even in patients without any clinical signs of intestinal involvement (3/12), sonographic changes were observed. In six patients with severe diarrhoea, sonographic signs of secretory diarrhoea were observed. In 4/12 patients, an increased arterial blood flow in the bowel wall was demonstrated as a typical characteristic of an inflammatory bowel process. In contrast, in 4/12 patients, ischaemic bowel wall lesions with high-resistance flow pattern in the SMA were found. These patients did not respond to immunosuppressive therapy and died. In conclusion, HRU is a useful tool for detecting acute bowel GvHD even before clinical symptoms. Moreover, HRU and CDI can be applied to define the severity of aGvHD and to identify patients with a poor prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11843829     DOI: 10.1046/j.1365-2141.2001.03221.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Sonographic signs of neutropenic enterocolitis.

Authors:  Christoph-F Dietrich; Stella Hermann; Stefan Klein; Barbara Braden
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 2.  Intestinal graft-versus-host disease: mechanisms and management.

Authors:  Hiroyuki Takatsuka; Tsuyoshi Iwasaki; Takahiro Okamoto; Eizo Kakishita
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  [Imaging of the small intestine: current knowledge].

Authors:  H E Adamek; C F Dietrich
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

4.  Assessment of acute intestinal graft versus host disease by abdominal magnetic resonance imaging at 3 Tesla.

Authors:  Johannes Budjan; Henrik J Michaely; Ulrike Attenberger; Stefan Haneder; Daniela Heidenreich; Sebastian Kreil; Florian Nolte; Wolf-Karsten Hofmann; Stefan O Schoenberg; Stefan A Klein
Journal:  Eur Radiol       Date:  2014-05-27       Impact factor: 5.315

Review 5.  Basic practices for gastrointestinal ultrasound.

Authors:  Mutsumi Nishida; Yuichi Hasegawa; Jiro Hata
Journal:  J Med Ultrason (2001)       Date:  2022-09-10       Impact factor: 1.878

Review 6.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

7.  Ultrasonographic evaluation of gastrointestinal graft-versus-host disease after hematopoietic stem cell transplantation.

Authors:  Mutsumi Nishida; Akio Shigematsu; Megumi Sato; Yusuke Kudo; Satomi Omotehara; Tatsunori Horie; Takahito Iwai; Tomoyuki Endo; Akihiro Iguchi; Hitoshi Shibuya; Kanako Hatanaka; Chikara Shimizu; Takanori Teshima
Journal:  Clin Transplant       Date:  2015-06-30       Impact factor: 2.863

Review 8.  New insight for the diagnosis of gastrointestinal acute graft-versus-host disease.

Authors:  Florent Malard; Mohamad Mohty
Journal:  Mediators Inflamm       Date:  2014-03-11       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.